✦ LIBER ✦

P126 Neoadjuvant treatment of stage II or III breast cancer with docetaxel and low dose capecitabine, with addition of trastuzumab for HER 2 amplified tumors

✍ Scribed by Q.J. Khan; P. Sharma; B.F. Kimler; J. Baranda; J.C. Andersen; J. Klemp; C.J. Fabian

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2129 POSTER An open-label study of capec

✍ D. Tripathy; C. Moisa; S. Glück 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Multicenter Phase II Trial of Neoadjuvan

✍ Glück, S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

A Phase II Trial of Split, Low-Dose Doce

✍ Orlando Silva; Gilberto Lopes; Daniel Morgenzstern; Christopher Lobo; Philomena 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

Phase II study of Docetaxel, Carboplatin

✍ L. Dirix; Benoy; A. Prové; H. Elst; J. Vandebroeck; H. Wuyts; M. Philips; I. Del 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Phase II Interventional Study (N0337) of

✍ Winston W. Tan; Jacob B. Allred; Muhammad Salim; Patrick Flynn; Paul A.S. Fishki 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 354 KB